Aaron Freidin Sells 1,816 Shares of Grail, Inc. (NASDAQ:GRAL) Stock

Grail, Inc. (NASDAQ:GRAL) CFO Aaron Freidin sold 1,816 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $56,659.20. Following the transaction, the chief financial officer now owns 335,170 shares of the company’s stock, valued at approximately $10,457,304. This represents a 0.54 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Grail Trading Up 10.5 %

Shares of NASDAQ GRAL opened at $29.74 on Friday. The stock has a 50 day simple moving average of $31.81 and a 200-day simple moving average of $21.29. Grail, Inc. has a 12-month low of $12.33 and a 12-month high of $63.99.

Grail (NASDAQ:GRAL) last announced its earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, topping the consensus estimate of ($4.41) by $2.55. The firm had revenue of $38.25 million for the quarter, compared to the consensus estimate of $35.33 million. As a group, equities analysts forecast that Grail, Inc. will post -15.15 earnings per share for the current year.

Institutional Investors Weigh In On Grail

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. FNY Investment Advisers LLC bought a new stake in Grail during the fourth quarter worth approximately $26,000. State of Tennessee Department of Treasury bought a new stake in Grail during the fourth quarter worth approximately $28,000. Lindbrook Capital LLC bought a new stake in Grail during the fourth quarter worth approximately $28,000. Sterling Capital Management LLC bought a new stake in Grail during the fourth quarter worth approximately $29,000. Finally, Wellington Shields Capital Management LLC bought a new stake in Grail during the fourth quarter worth approximately $33,000.

Analyst Ratings Changes

GRAL has been the subject of several analyst reports. Morgan Stanley initiated coverage on Grail in a research report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price objective for the company. Wolfe Research initiated coverage on Grail in a research report on Friday, November 15th. They set a “peer perform” rating for the company.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.